3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
5
Gastro-enteropancreatic neuroendocrine tumor
2
Thymus Neoplasms
1
Rhabdomyosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Lymphoma
1
Central Nervous System Neoplasms
1
Interventions
zimberelimab
1
pembrolizumab
1
olaparib
1
lutetium Lu 177 dotatate
1
lanreotide
1
fluorodopa F 18
1
cabozantinib
1
Sunitinib
1
Random Allocation
1
Octreotide
1
Nivolumab
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoid Tumor
×
177Lu-octreotide, DOTA(0)-Tyr(3)-
×
1 year
×
Clear all
No trials found.